ginnalin-a has been researched along with Hypoglycemia* in 1 studies
1 other study(ies) available for ginnalin-a and Hypoglycemia
Article | Year |
---|---|
Pycnalin, a new α-glucosidase inhibitor from Acer pycnanthum.
A new compound, pycnalin (1), together with four known compounds, ginnalins A (2), B (3), C (4), and 3,6-di-O-galloyl-1,5-anhydro-D-glucitol (3,6-di-GAG) (5), were isolated from Acer pycnanthum. The structure of 1 was determined on the basis of 2D-NMR spectral data and synthesis of 1. Pycnalin (1) is the first 1,5-anhydro-D-mannitol linked to a gallic acid, while compounds 2-5 were 1,5-anhydro-D-glucitol linked to gallic acids. All compounds were tested in vitro for α-glucosidase inhibitory and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities. Pycnalin (1) exhibited moderate α-glucosidase inhibitory activity as well as free radical scavenging activity. Ginnalin A (2) and 3,6-di-GAG (5), which have two galloyl groups, exhibited potent α-glucosidase inhibition, compared to those of other compounds 1, 3, and 4 containing a galloyl group. These results suggest that α-glucosidase inhibition is influenced by the number of galloyl groups. Topics: Acer; Biphenyl Compounds; Deoxyglucose; Enzyme Inhibitors; Free Radical Scavengers; Gallic Acid; Glycoside Hydrolase Inhibitors; Glycosides; Humans; Hypoglycemia; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Picrates; Plant Extracts; Sorbitol | 2011 |